Boston Scientific Corp (BSX)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	1,853,000	1,593,000	698,000	1,041,000	-140,000
Revenue	US$ in thousands	16,747,000	14,240,000	12,682,000	11,888,000	9,913,000
Net profit margin		11.06%	11.19%	5.50%	8.76%	-1.41%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $1,853,000K ÷ $16,747,000K
= 11.06%

To analyze Boston Scientific Corp's net profit margin over the five-year period from December 31, 2020, to December 31, 2024, we observe the following trend:

- In December 2020, the net profit margin was negative at -1.41%, indicating that the company's expenses exceeded its revenues, leading to a loss on its bottom line.

- By December 2021, there was a significant turnaround as the net profit margin improved to 8.76%, reflecting a positive net income relative to its revenue, which suggests enhanced profitability for the company.

- In December 2022, the net profit margin slightly declined to 5.50%, indicating a moderation in profitability from the previous year but still staying above the baseline.

- The following year, by December 2023, there was a notable increase in the net profit margin to 11.19%, demonstrating a solid growth in profitability for Boston Scientific Corp.

- Finally, as of December 2024, the net profit margin remained strong at 11.06%, indicating that the company effectively managed its expenses in relation to its revenue, maintaining a healthy level of profitability.

Overall, the analysis suggests that Boston Scientific Corp experienced fluctuations in its net profit margin over the five-year period, with notable improvements in profitability from 2021 onwards, reaching strong levels by the end of 2024.